Skip to content

Participatory Research for Suicide Prevention in Autism

Participatory Research for Suicide Prevention in Autism

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06552871
Enrollment
51
Registered
2024-08-14
Start date
2024-09-05
Completion date
2025-08-05
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism, Suicide Prevention

Keywords

educational intervention, pilot test

Brief summary

The goal of this study is to pilot test a new educational intervention for organization members focused on suicide prevention for autistic people. The main questions it aims to answer are: * Does participating in the intervention increase participants' knowledge, skills, and actions to support suicide prevention for autistic people? * What feedback do participants have to help improve the intervention? Participants will: * engage in a four-part virtual educational intervention * answer questions via online survey before, after, and 3-months after the intervention * participate in an optional interview to provide feedback

Detailed description

This study will pilot test a new four-part virtual educational intervention called Forming Love around Autistic People to Prevent Suicide (FLAPS). Participants will be active members of an organization (e.g., paid employee, volunteer, stakeholder) whose work impacts autistic people. They will participate in four virtual educational sessions led by trained facilitators. The educational intervention will provide current research evidence and community-informed information about suicide risk and prevention, and engage participants in active discussions to expand their knowledge and skills as well as to promote action planning to support suicide prevention for autistic people in their community. Participants will provide demographic and descriptive information and complete the Steps Toward Prevention (Autism Community Suicide Prevention) measure at three time-points (Pre-intervention, post-intervention \[approximately 2 months after baseline\], and 3-months after intervention). The Steps Toward Prevention (Autism Community Suicide Prevention) measure will assess participants' knowledge, skills, and actions to support suicide prevention for autistic people. They will also be provided an option to complete a short interview to provide feedback about the FLAPS intervention.

Interventions

BEHAVIORALForming Love around Autistic People to Prevent Suicide

Four-part virtual educational intervention

Sponsors

University of Utah
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Initial pre-post pilot test

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Active member of an organization whose work impacts autistic people * Age 18+ * Fluent English language to participate in virtual educational intervention

Exclusion criteria

* No access to an internet-connected device * Unable to participate in a virtual educational intervention

Design outcomes

Primary

MeasureTime frameDescription
Steps Toward Prevention - Autism Community Suicide Prevention: Knowledge & CapacityPre-intervention, post-intervention (approximately 2 months after baseline), and 3-months after interventionSelf-report measure of knowledge, skills, and actions to support suicide prevention for autistic people. This reported data is for the Knowledge \& Capacity scale of the Steps Toward Prevention - Autism Community Suicide Prevention measure. This scale inquires about how true eight statements are for the respondent currently on a 5-point scale (Definitely not true - Definitely true). Scores are averaged across the items (1-5 possible range). Higher numbers indicate greater knowledge and capacity for suicide prevention.
Steps Toward Prevention - Autism Community Suicide Prevention: ActionsPre-intervention, post-intervention (approximately 2 months after baseline), and 3-months after interventionSelf-report measure of knowledge, skills, and actions to support suicide prevention for autistic people. This reported data is for the Actions scale of the Steps Toward Prevention - Autism Community Suicide Prevention measure. This inquires about how often the respondent has done twelve types of actions in the past month on a 5-point scale (Never - More than once a week). Scores are averaged across the items (1-5 possible range). Higher numbers indicate greater engagement in actions for suicide prevention.

Secondary

MeasureTime frameDescription
Qualitative InterviewPost intervention (approximately 2 months after baseline)Open-ended interview questions to understand additional outcomes that participants experienced that they attribute to the intervention.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAnne V Kirby, PhD

University of Utah

Baseline characteristics

Characteristic
Age, Customized
Age
18-29 years
8 Participants
Age, Customized
Age
30-39 years
17 Participants
Age, Customized
Age
40-49 years
14 Participants
Age, Customized
Age
50-59 years
8 Participants
Age, Customized
Age
60+ years
4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
14 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
35 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Organization (anonymized)
AA
1 Participants
Organization (anonymized)
AB
2 Participants
Organization (anonymized)
AC
9 Participants
Organization (anonymized)
AD
6 Participants
Organization (anonymized)
AE
4 Participants
Organization (anonymized)
BA
5 Participants
Organization (anonymized)
BB
1 Participants
Organization (anonymized)
BC
2 Participants
Organization (anonymized)
BD
1 Participants
Organization (anonymized)
CA
15 Participants
Organization (anonymized)
CB
5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
45 Participants
Sex/Gender, Customized
Sex
Female
40 Participants
Sex/Gender, Customized
Sex
Male
8 Participants
Sex/Gender, Customized
Sex
Other/Choose not to respond
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026